Advertisement
UK markets close in 6 hours 2 minutes
  • FTSE 100

    8,076.50
    +31.69 (+0.39%)
     
  • FTSE 250

    19,785.55
    -14.17 (-0.07%)
     
  • AIM

    754.58
    -0.29 (-0.04%)
     
  • GBP/EUR

    1.1627
    -0.0001 (-0.01%)
     
  • GBP/USD

    1.2433
    -0.0020 (-0.16%)
     
  • Bitcoin GBP

    53,472.79
    +216.58 (+0.41%)
     
  • CMC Crypto 200

    1,431.99
    +7.89 (+0.55%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CRUDE OIL

    82.93
    -0.43 (-0.52%)
     
  • GOLD FUTURES

    2,329.50
    -12.60 (-0.54%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,181.48
    +43.83 (+0.24%)
     
  • CAC 40

    8,118.60
    +12.82 (+0.16%)
     

Down 78% in 1 Year, Is There Any Hope Left for Invitae?

Down 78% in 1 Year, Is There Any Hope Left for Invitae?

With shares down by 91% in the last three years, and 78% in the last 12 months alone, Invitae (NYSE: NVTA) and its investors are bound to be feeling the burn. The genetic testing company's downward spiral led Wall Street analysts to downgrade the stock, and many are suggesting that shareholders quit their positions. Let's explore how realistic it is for Invitae to make a comeback so that you'll know whether the odds are in your favor.